Fig. 5From: Nomogram for predicting advanced liver fibrosis and cirrhosis in patients with chronic liver diseaseLiver fibrosis decision curve analysis. Decision curve analysis depict the clinical net benefit. NomogramS3S4 is compared with APRI, FIB-4, and GPR for predicting advanced fibrosis in the training set (a); NomogramS4 is compared with APRI, FIB-4, and GPR for predicting cirrhosis in the validation set (b); NomogramS3S4 is compared with APRI, FIB-4, and GPR for predicting advanced fibrosis in the training set (c); NomogramS4 is compared with APRI, FIB-4, and GPR for predicting cirrhosis in the validation set (d). Black line = net benefit when no patient will experience the event; gray line = net benefit when all patients will experience the event. The preferred markers is the marker with the highest net benefit at any given thresholdBack to article page